HOME
 
   
 
Competitive Analysis of Other Anti-Wrinkle Treatments

Below you will find a comprehensive comparison to other anti-aging products currently available. The chart below clearly reflects ProPLEXIN-CR's over-whelming superiority in both formula complexity and potency. Click on any ingredient's name for detailed information about its functionality.
 
Functional Components ProPLEXIN-CR™ StriVectin-SD™ Hydroderm™ Rejuvenex™ Avotone™
Argireline™
(AH-3) 10% 		YES NO NO NO YES
Matrixyl™ 3000 YES NO NO1 NO NO
Dermaxyl™ YES NO NO NO NO
Dermox™ YES NO NO NO NO
Hyaluronic
Acid		 YES NO NO NO NO
Calmosensine™ YES NO NO NO NO
L-Ascorbic
Acid 2 		YES NO NO NO NO
Isoflavone™ YES NO NO NO NO
Antacticine™ YES NO NO NO NO
Elastin YES NO NO NO NO
Collagen YES NO YES NO NO
Soy YES NO NO NO NO
Vitamin E YES NO NO NO NO
Alpha Lipoic Acid NO2 NO NO YES NO
DMAE NO2 NO NO YES NO
Ester C™ NO2 NO NO YES NO
   
 
Competitor Functional Component Information
(Refers to the ProPLEXIN-CR™ competitor comparison chart above)

1. Hydroderm™, Nexiderm™: These products only contain Matrixyl™, not Matrixyl™ 3000 which is used in ProPLEXIN-CR™. Independent testing of Matrixyl™ and Matrixyl™ 3000 has shown Matrixyl™ 3000 to be 17.2% more effective than standard Matrixyl™ with up to a 1.6 fold visible improvement in facial orbital wrinkles.


2. Rejuvenex™: The dermal benefits of Alpha Lipoic Acid, DMAE and Ester C are well established and, within the framework of this reference, undisputed. However, ProPLEXIN-CR™ contains several ingredients, which, synergistically, far surpass any of the benefits offered by these 3 ingredients. Additionally, ECR's original product profile for ProPLEXIN-CR™ specified the possible inclusion of Alpha Lipoic Acid and DMAE contingent upon the legal use of these ingredients. However, our product development team saw no significant beneficial advantages for the inclusion of these components, as it would have lead to functional redundancies in the formula.

3. Bioque Serum XL™: Bioque Serum XL™ contains 20% Argiriline™ (AH3). This exceeds the manufacturer's recommended safe maximum dosage of 10%. There is an increased risk of adverse reactions in concentrations above 10%. Independent tests have shown no additional efficacy in concentrations over 10%.

  
 
® 2003 EC RESEARCH CORP.   ALL RIGHTS RESERVED.   EFFECTIVENESS GUARANTEE    PRIVACY